Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-12

FDA Approved: BUMETANIDE — Original Application (Rising Pharma Holdings, Inc)

View source ↗

Summary

FDA approved an original ANDA for bumetanide from Rising Pharma Holdings, Inc, making the generic diuretic available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

ORIG AP for BUMETANIDE (BUMETANIDE)